Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Sept 2026 for Atara Biotherapeutics, Inc., €860k.
Filing timeline
BuySaleBrian N. Cherry
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -7.8%Entry US$10.23 · Close 22 Oct 2026 US$9.43
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian N. Cherry: trading record in brief
Brian N. Cherry discloses dealings in Atara Biotherapeutics, Inc. to SEC (Form 4). Between 11 June 2026 and 4 September 2026, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €860k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.
Most recently, on 4 September 2026, the filings show an open-market purchase worth €860k in Atara Biotherapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brian N. Cherry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
104,166 shares@ US$9.601.14% mcap100.0% of flowCommon StockSEC:0000905148-26-004085:0
Canonical exit: 3 Dec 2026 (T+90)
24,000 sharesCommon StockSEC:0000905148-26-002951:0
2 of 2 declarations
